Abstract
Tumor cells are not only susceptible to signals from the environment, but they likewise release signal substances. It is well known that tumor cells secrete angiogenic factors - most prominently the vascular endothelial growth factor - which initiate the vascularization of the tumor for its nourishment. This process has been termed neoangiogenesis. Besides this, two further processes have recently been discovered that facilitate the interaction of the tumor with the lymphatic system and the nervous system, named lymphangiogenesis and neoneurogenesis. These three “geneses” have a cognate, in part common regulation and conjointly promote metastasis development. Neoangiogenesis and lymphangiogenesis provide the structures for the two routes of tumor cell dissemination, i.e. either hematogenous or lymphatic. Neoneurogenesis accomplishes the innervation of the tumor by the ingrowth of nerve endings into the tumor and alternatively or additionally by the protection of existing nerve cells from destruction. These tumor-innervating nerve cells may release neurotransmitters which are proliferative or promigratory signals for the tumor cells. Furthermore, nerve fibers are used as routes for tumor cell dissemination, too, which is known as perineural invasion.
Keywords: Neoangiogenesis, lymphangiogenesis, neoneurogenesis, perineural invasion, metastasis formation
Current Pharmaceutical Design
Title: Connecting A Tumor to the Environment
Volume: 13 Issue: 33
Author(s): Frank Entschladen, Daniel Palm, Theodore L. Drell IV,, Kerstin Lang and Kurt S. Zaenker
Affiliation:
Keywords: Neoangiogenesis, lymphangiogenesis, neoneurogenesis, perineural invasion, metastasis formation
Abstract: Tumor cells are not only susceptible to signals from the environment, but they likewise release signal substances. It is well known that tumor cells secrete angiogenic factors - most prominently the vascular endothelial growth factor - which initiate the vascularization of the tumor for its nourishment. This process has been termed neoangiogenesis. Besides this, two further processes have recently been discovered that facilitate the interaction of the tumor with the lymphatic system and the nervous system, named lymphangiogenesis and neoneurogenesis. These three “geneses” have a cognate, in part common regulation and conjointly promote metastasis development. Neoangiogenesis and lymphangiogenesis provide the structures for the two routes of tumor cell dissemination, i.e. either hematogenous or lymphatic. Neoneurogenesis accomplishes the innervation of the tumor by the ingrowth of nerve endings into the tumor and alternatively or additionally by the protection of existing nerve cells from destruction. These tumor-innervating nerve cells may release neurotransmitters which are proliferative or promigratory signals for the tumor cells. Furthermore, nerve fibers are used as routes for tumor cell dissemination, too, which is known as perineural invasion.
Export Options
About this article
Cite this article as:
Entschladen Frank, Palm Daniel, Drell IV, L. Theodore, Lang Kerstin and Zaenker S. Kurt, Connecting A Tumor to the Environment, Current Pharmaceutical Design 2007; 13 (33) . https://dx.doi.org/10.2174/138161207782360573
DOI https://dx.doi.org/10.2174/138161207782360573 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules
Current Medicinal Chemistry <i>In Silico</i> Docking Studies of Vascular Endothelial Growth Factor-A (VEGFA): Possible Implications in Chronic Myeloid Leukemia (CML) Therapy
Current Proteomics Bortezomib in the Treatment of Cancer
Recent Patents on Anti-Cancer Drug Discovery Apoptosis Imaging to Monitor Cancer Therapy: The Road to Fast Treatment Evaluation?
Current Pharmaceutical Biotechnology Investigation of Human Papilloma Virus Associated with Oral Cancer with an Insight into Diagnostic Approaches and Recent Patents
Recent Patents on Biomarkers Anti-Egfr Therapy in Colorectal Cancer: How to Choose The Right Patient
Current Drug Targets Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design 89Zr Radiochemistry for Positron Emission Tomography
Medicinal Chemistry Curcumin: A Promising Agent Targeting Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Ruthenium Complexes as Anticancer Agents
Current Medicinal Chemistry Characterization of Stem-Like Cells Directly Isolated from Freshly Resected Laryngeal Squamous Cell Carcinoma Specimens
Current Stem Cell Research & Therapy Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets Standards and Novel Therapeutic Options in the Treatment of Patients with Soft Tissue Sarcoma
Reviews on Recent Clinical Trials Dietary Manipulation of Precursor Polyunsaturated Fatty Acids Modulates Eicosanoid and Endocannabinoid Synthesis: A Potential Tool to Control Tumor Development
Current Nutrition & Food Science Mutations of Chromatin Structure Regulating Genes in Human Malignancies
Current Protein & Peptide Science Magnetic Resonance Imaging of Uncommon Hepatic Mesenchymal Tumours: Haemangioendothelioma and Angiosarcoma
Current Medical Imaging Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
Current Medicinal Chemistry Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells
Current Cancer Drug Targets Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy
Current Cancer Drug Targets Molecular Targeted Therapy in Melanoma: A Way to Reverse Resistance to Conventional Drugs
Current Drug Delivery